(Bloomberg) -- Pharmaceutical stocks are headed for their biggest annual gain since 2000 after a new U.S. drug insurance program and industrywide job cuts helped profits beat analysts' estimates.
The 14-member Standard and Poor's 500 Pharmaceuticals Index added 8.4 percent since Jan. 1, led by a 35 percent rise by Schering-Plough Corp. and a 31 percent advance by King Pharmaceuticals Inc. The eight largest U.S. drugmakers beat first-quarter earnings estimates this month and half raised their forecasts, a trend analysts say may continue through 2007.
Read more at Bloomberg Stocks News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment